The major stock averages are mixed at midday, with the Dow lagging following its outperformance yesterday and the Nasdaq bouncing back from several days of...
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Repligen (RGEN) initiated with an Overweight at JPMorgan. 2....
HIGHER: Adamis Pharmaceuticals (ADMP), up 5% after it submitted an IND application to the FDA for an opioid overdose drug candidate. DOWN AFTER EARNINGS: ascena...
Jefferies analyst Eun Yang views the post-Phase 2 data selloff today in shares of RA Pharmaceuticals (RARX) as overreaction. The interim data show RA's RA101495...
Ra Pharmaceuticals (RARX) announced that its RA101495 SC for the treatment of paroxysmal nocturnal hemoglobinuria met the primary endpoint in the Eculizumab native cohort in...